| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |